Featured Research

from universities, journals, and other organizations

New way to rate severity of colitis, a common cause of diarrhea

Date:
December 5, 2011
Source:
Mayo Clinic
Summary:
Researchers have developed a new way to assess a common cause of chronic diarrhea, microscopic colitis, using the Microscopic Colitis Disease Activity Index. The index provides a consistent way to assess the condition's severity.

Mayo Clinic researchers have developed a new way to assess a common cause of chronic diarrhea, microscopic colitis, using the Microscopic Colitis Disease Activity Index. A study describing the index was released October 31 during the American College of Gastroenterology 2011 Annual Scientific Meeting and Postgraduate Course in Washington. The index provides a consistent way to assess the condition's severity.

"Until now, physicians have not had a way to objectively and consistently score the severity of a patient's disease beyond simply counting the number of bowel movements per day," says author Darrell Pardi, M.D., a Mayo Clinic gastroenterologist. The assessment also accounts for symptoms other than diarrhea, such as abdominal pain, urgency, and incontinence.

"This assessment is a significant step forward, as it correlates a patient's symptoms with the physicians' understanding of the severity of microscopic colitis," Dr. Pardi says. Using the assessment index in future studies, researchers will more easily compare treatments for this condition.

Microscopic colitis is recognized as a common cause of chronic diarrhea, causing perhaps 30 percent of all cases of the condition in older patients. Microscopic colitis is a chronic, inflammatory condition of the large intestine (colon) that causes watery diarrhea and, sometimes, abdominal pain. The disorder gets its name from the microscopic examination of tissue required to identify it.

Other study authors include: Rami F. Abboud, M.D.; Meredith McNally, M.D.; William J. Tremaine, M.D.; William J. Sandborn, M.D.; Patricia P. Kammer, M.D.; W. Scott Harmsen, M.D.; Alan R. Zinsmeister, M.D.; Edward V. Loftus, M.D.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "New way to rate severity of colitis, a common cause of diarrhea." ScienceDaily. ScienceDaily, 5 December 2011. <www.sciencedaily.com/releases/2011/10/111031132213.htm>.
Mayo Clinic. (2011, December 5). New way to rate severity of colitis, a common cause of diarrhea. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/10/111031132213.htm
Mayo Clinic. "New way to rate severity of colitis, a common cause of diarrhea." ScienceDaily. www.sciencedaily.com/releases/2011/10/111031132213.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins